全文获取类型
收费全文 | 8015篇 |
免费 | 412篇 |
国内免费 | 194篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 106篇 |
妇产科学 | 1171篇 |
基础医学 | 1152篇 |
口腔科学 | 241篇 |
临床医学 | 331篇 |
内科学 | 180篇 |
皮肤病学 | 48篇 |
神经病学 | 65篇 |
特种医学 | 100篇 |
外科学 | 3416篇 |
综合类 | 805篇 |
预防医学 | 432篇 |
眼科学 | 21篇 |
药学 | 272篇 |
3篇 | |
中国医学 | 126篇 |
肿瘤学 | 95篇 |
出版年
2024年 | 23篇 |
2023年 | 92篇 |
2022年 | 139篇 |
2021年 | 309篇 |
2020年 | 237篇 |
2019年 | 221篇 |
2018年 | 260篇 |
2017年 | 247篇 |
2016年 | 213篇 |
2015年 | 239篇 |
2014年 | 425篇 |
2013年 | 500篇 |
2012年 | 352篇 |
2011年 | 426篇 |
2010年 | 345篇 |
2009年 | 324篇 |
2008年 | 335篇 |
2007年 | 355篇 |
2006年 | 347篇 |
2005年 | 305篇 |
2004年 | 306篇 |
2003年 | 274篇 |
2002年 | 276篇 |
2001年 | 196篇 |
2000年 | 167篇 |
1999年 | 193篇 |
1998年 | 126篇 |
1997年 | 122篇 |
1996年 | 177篇 |
1995年 | 135篇 |
1994年 | 118篇 |
1993年 | 97篇 |
1992年 | 99篇 |
1991年 | 75篇 |
1990年 | 77篇 |
1989年 | 60篇 |
1988年 | 64篇 |
1987年 | 47篇 |
1986年 | 37篇 |
1985年 | 45篇 |
1984年 | 45篇 |
1983年 | 31篇 |
1982年 | 34篇 |
1981年 | 28篇 |
1980年 | 30篇 |
1979年 | 20篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1975年 | 8篇 |
1974年 | 5篇 |
排序方式: 共有8621条查询结果,搜索用时 218 毫秒
1.
2.
3.
目的探究N6-甲基腺嘌呤(m6A)去甲基化酶ALKBH5与弱精症的相关性。方法收集精液标本30份,包括弱精症患者与健康者精液标本各15份,密度梯度离心纯化精子,使用液相色谱与质谱联用(LC-MS/MS)检测精子RNA的m6A水平,使用实时荧光定量PCR法检测ALKBH5相对表达水平。结果弱精症患者m6A水平明显高于健康者,ALKBH5相对表达水平低于健康者,差异均有统计学意义(P<0.05)。精子活动度参数相关性分析结果显示,ALKBH5相对表达水平与前向运动精子数和非前向运动精子数呈正相关(r=0.512、0.377,P<0.05),与不动精子数呈负相关(r=-0.497,P<0.05);m6A与前向运动精子数和非前向运动精子数呈负相关(r=-0.442、-0.425,P<0.05),与不动精子数呈正相关(r=0.528,P<0.05)。结论在弱精症患者中,m6A及其去甲基化酶ALKBH5与精子活动度具有相关性。 相似文献
4.
5.
Various techniques of reconstruction of deformed Charcot hindfoot using different internal fixation devices have been described in the literature. We present our surgical technique using specific principles that has resulted in improved outcomes to allow correction of deformity, obtain stability and allow progression to weightbearing in orthotic shoes. We describe our preoperative evaluation, planning and surgical timing. We also hope to share some technical pearls and details on the finer points to achieve a satisfactory correction and reduce the learning curve. 相似文献
6.
7.
8.
9.
Selcen Yuksel Selim Ayhan Vugar Nabiyev Montse Domingo-Sabat Alba Vila-Casademunt Ibrahim Obeid Francisco Sanchez Perez-Grueso Emre Acaroglu 《The spine journal》2019,19(1):71-78
BACKGROUND CONTEXT
Health-related quality of life (HRQOL) parameters have been shown to be reliable and valid in patients with adult spinal deformity (ASD). Minimum clinically important difference (MCID) has become increasingly important to clinicians in evaluating patients with a threshold of improvement that is clinically relevant.PURPOSE
To calculate MCID and minimum detectable change (MDC) values of total scores of the Core Outcome Measures Index (COMI), Oswestry Disability Index (ODI), Physical Component Summary (PCS), Mental Component Summary (MCS) of the Short Form 36 (SF-36), and Scoliosis Research Society 22R (SRS-22R) in surgically and nonsurgically treated ASD patients who have completed an anchor question at pretreatment and 1-year follow-up.STUDY DESIGN/SETTING
Prospective cohort.PATIENT SAMPLE
Surgical and nonsurgical patients from a multicenter ASD database.OUTCOME MEASURES
Self-reported HRQOL measures (COMI, ODI, SF-36, SRS-22R, and anchor question).METHODS
A total of 185 surgical and 86 nonsurgical patients from a multicenter ASD database who completed pretreatment and 1-year follow-up HRQOL scales and the anchor question at the first year follow-up were included. The anchor question was used to determine MCID for each HRQOL measure. MCIDs were calculated by an anchor-based method using latent class analysis (LCA) and MDCs by a distribution-based method.RESULTS
All differences between means of baseline and first year postoperative total score measures for all scales demonstrated statistically significant improvements in the overall population as well as the surgically treated patients but not in the nonsurgical group. The calculated MDC and MCID values of HRQOL parameters in the entire study population were 1.34 and 2.62 for COMI, 10.65 and 14.31 for ODI, 6.09 and 7.33 for SF-36 PCS, 6.14 and 4.37 for SF-36 MCS, and 0.42 and 0.71 for SRS-22R. The calculated MCID values for surgical and non-surgical treatment groups were 2.76 versus 1.20 for COMI, 14.96 versus 2.45 for ODI, 7.83 versus 2.15 for SF-36 PCS, 5.14 versus 2.03 for SF-36 MCS, and 0.94 versus 0.11 for SRS-22R; the MDC values for surgical and nonsurgical treatment groups were 1.22 versus 1.51 for COMI, 10.27 versus 9.45 for ODI, 5.16 versus 6.77 for SF-36 PCS, 6.05 versus 5.67 for SF-36 MCS, and 0.38 versus 0.43 for SRS-22R.CONCLUSIONS
This study has demonstrated that MCID calculations for the HRQOL scales in ASD using LCA yield values comparable to other studies that had used different methodologies. The most important finding was the significantly different MCIDs for COMI, ODI, SF-36 PCS and SRS-22 in the surgically and nonsurgically treated cohorts. This finding suggests that a universal MCID value, inherent to a specific HRQOL for an entire cohort of ASD may not exist. Use of different MCIDs for surgical and nonsurgical patients may be warranted. 相似文献10.